Human Paraoxonase 1 Hydrolysis of Nanomolar Chlorpyrifos-oxon Concentrations is Unaffected by Phenotype or Q192R Genotype

Overview

Journal Toxicol Lett

Publisher Elsevier

Specialty Toxicology

Date 2014 Aug 6

PMID 25093614

Citations 3

Authors

R Hunter Coombes

Edward C Meek

Mary Beth Dail

Howard W Chambers

Janice E Chambers

Affiliations

Soon will be listed here.

Abstract

The organophosphorus insecticide chlorpyrifos has been widely used. Its active metabolite chlorpyrifos-oxon (CPO) is a potent anticholinesterase and is detoxified by paraoxonase 1 (PON1). PON1 activity is influenced by numerous factors including a Q192R polymorphism. Using forty human blood samples bearing homozygous genotypes and either high or low activity phenotypes (as determined by high concentration assays of paraoxon and diazoxon hydrolysis) the serum PON1 hydrolysis of high (320 μM) and low (178 nM) CPO concentrations was assessed using direct or indirect spectrophotometric methods, respectively. PON1 activity at high CPO concentration reflected the phenotype and genotype differences; subjects with the high activity phenotype and homozygous for the PON1R192 alloform hydrolyzed significantly more CPO than subjects with the low activity phenotype and/or PON1Q192 alloform (high RR=11023±722, low RR=9467±798, high QQ=8809±672, low QQ=6030±1015 μmol CPO hydrolyzed/min/L serum). However, PON1 hydrolysis of CPO at the lower, more environmentally relevant concentration showed no significant differences between the PON1192 genotypes and/or between high and low activity phenotypes (high RR=231±27, low RR=219±52, high QQ=193±59, low QQ=185±43 nmol CPO/min/L serum). Low CPO concentrations were probably not saturating, so PON1 did not display maximal velocity and the PON1 genotype/phenotype might not influence the extent of metabolism at environmental exposures.

Citing Articles

Reproductive Health Risks Associated with Occupational and Environmental Exposure to Pesticides.

Fucic A, Duca R, Galea K, Maric T, Garcia K, Bloom M Int J Environ Res Public Health. 2021; 18(12).

PMID: 34207279 PMC: 8296378. DOI: 10.3390/ijerph18126576.

Interaction between prenatal pesticide exposure and a common polymorphism in the gene on DNA methylation in genes associated with cardio-metabolic disease risk-an exploratory study.

Declerck K, Remy S, Wohlfahrt-Veje C, Main K, Van Camp G, Schoeters G Clin Epigenetics. 2017; 9:35.

PMID: 28396702 PMC: 5382380. DOI: 10.1186/s13148-017-0336-4.

Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Mackness M, Mackness B Gene. 2015; 567(1):12-21.

PMID: 25965560 PMC: 4458450. DOI: 10.1016/j.gene.2015.04.088.

References

ALDRIDGE W, Davison A . The mechanism of inhibition of cholinesterases by organophosphorus compounds. Biochem J. 1953; 55(5):763-6. PMC: 1269530. DOI: 10.1042/bj0550763. View

HUMBERT R, Adler D, Disteche C, Hassett C, Omiecinski C, Furlong C . The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet. 1993; 3(1):73-6. DOI: 10.1038/ng0193-73. View

Li W, Costa L, Richter R, Hagen T, Shih D, Tward A . Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics. 2001; 10(9):767-79. DOI: 10.1097/00008571-200012000-00002. View

Shih D, Gu L, Xia Y, Navab M, Li W, Hama S . Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 1998; 394(6690):284-7. DOI: 10.1038/28406. View

Furlong C, Richter R, Seidel S, Costa L, Motulsky A . Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem. 1989; 180(2):242-7. DOI: 10.1016/0003-2697(89)90424-7. View

Neal R . Studies of the enzymic mechanism of the metabolism of diethyl 4-nitrophenyl phosphorothionate (parathion) by rat liver microsomes. Biochem J. 1967; 105(1):289-97. PMC: 1198300. DOI: 10.1042/bj1050289. View

Davies H, Richter R, Keifer M, Broomfield C, Sowalla J, Furlong C . The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet. 1996; 14(3):334-6. DOI: 10.1038/ng1196-334. View

Chambers J, Ma T, Boone J, CHAMBERS H . Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the rat. Life Sci. 1994; 54(18):1357-64. DOI: 10.1016/0024-3205(94)00515-x. View

GAINES T . Acute toxicity of pesticides. Toxicol Appl Pharmacol. 1969; 14(3):515-34. DOI: 10.1016/0041-008x(69)90013-1. View

10.

Jansen K, Cole T, Park S, Furlong C, Costa L . Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds. Toxicol Appl Pharmacol. 2009; 236(2):142-53. PMC: 2717945. DOI: 10.1016/j.taap.2009.02.001. View

11.

Costa L, McDonald B, Murphy S, Omenn G, Richter R, Motulsky A . Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats. Toxicol Appl Pharmacol. 1990; 103(1):66-76. DOI: 10.1016/0041-008x(90)90263-t. View

12.

Cole T, Walter B, Shih D, Tward A, Lusis A, Timchalk C . Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet Genomics. 2005; 15(8):589-98. DOI: 10.1097/01.fpc.0000167327.08034.d2. View

13.

Sorenson R, Bisgaier C, Aviram M, Hsu C, Billecke S, La Du B . Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol. 1999; 19(9):2214-25. DOI: 10.1161/01.atv.19.9.2214. View

14.

Sogorb M, Vilanova E . Serum albumins and detoxication of anti-cholinesterase agents. Chem Biol Interact. 2010; 187(1-3):325-9. DOI: 10.1016/j.cbi.2010.03.001. View

15.

Stevens R, Suzuki S, Cole T, Park S, Richter R, Furlong C . Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc Natl Acad Sci U S A. 2008; 105(35):12780-4. PMC: 2529096. DOI: 10.1073/pnas.0805865105. View

16.

Pond A, Coyne C, CHAMBERS H, Chambers J . Identification and isolation of two rat serum proteins with A-esterase activity toward paraoxon and chlorpyrifos-oxon. Biochem Pharmacol. 1996; 52(2):363-9. DOI: 10.1016/0006-2952(96)00215-8. View

17.

Eckerson H, Romson J, Wyte C, La Du B . The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet. 1983; 35(2):214-27. PMC: 1685526. View

18.

Cole T, Jampsa R, Walter B, Arndt T, Richter R, Shih D . Expression of human paraoxonase (PON1) during development. Pharmacogenetics. 2003; 13(6):357-64. DOI: 10.1097/00008571-200306000-00007. View

19.

Li W, Furlong C, Costa L . Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol Lett. 1995; 76(3):219-26. DOI: 10.1016/0378-4274(95)80006-y. View

20.

Ellman G, COURTNEY K, ANDRES Jr V, FEATHER-STONE R . A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7:88-95. DOI: 10.1016/0006-2952(61)90145-9. View